UBS Cuts Price Target on Amgen to $280 From $326, Maintains Neutral Rating

Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
293.54 USD | -1.42% |
|
+2.84% | +12.62% |
Feb. 06 | Daiwa Securities Adjusts Amgen's Price Target to $350 From $360 | MT |
Feb. 06 | Trump faces pressure from US industry over China tariff on medicines | RE |